[1] Mendis, S., Davis, S. and Norrving, B. (2015) Organizational Update The World Health Organization Global Status Report on Noncommunicable Diseases 2014; One More Landmark Step in the Combat Against Stroke and Vascular Disease. Stroke, 46, e121-e122.
http://dx.doi.org/10.1161/STROKEAHA.115.008097
[2] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108.
http://dx.doi.org/10.3322/caac.21262
[3] Riley, L., Guthold, R., Cowan, M., Savin, S., Bhatti, L., Armstrong, T., et al. (2016) The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. American Journal of Public Health, 106, 74-78.
http://dx.doi.org/10.2105/AJPH.2015.302962
[4] Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30.
http://dx.doi.org/10.3322/caac.21332
[5] Lam, W., Chan, C., Chan, C., Mak, C., Chong, K., Leung, M., et al. (2008) Factors Affecting the Palpability of Breast Lesion by Self-Examination. Singapore Medical Journal, 49, 228.
[6] Anderson, B.O. and Jakesz, R. (2008) Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative. World Journal of Surgery, 32, 2578-2585.
http://dx.doi.org/10.1007/s00268-007-9454-z
[7] Rizwan, M. and Saadullah, M. (2009) Lack of Awareness about Breast Cancer and Its Screening in Developing Countries. Indian Journal of Cancer, 46, 252.
http://dx.doi.org/10.4103/0019-509X.52969
[8] Montazeri, A., Vahdaninia, M., Harirchi, I., Harirchi, A.M., Sajadian, A., Khaleghi, F., et al. (2008) Breast Cancer in Iran: Need for Greater Women Awareness of Warning Signs and Effective Screening Methods. Asia Pacific Family Medicine, 7, 1.
http://dx.doi.org/10.1186/1447-056X-7-6
[9] Harirchi, I., Ebrahimi, M., Zamani, N., Jarvandi, S. and Montazeri, A. (2000) Breast Cancer in Iran: A Review of 903 Case Records. Public Health, 114, 143-145.
http://dx.doi.org/10.1016/s0033-3506(00)00324-3
[10] Mousavi, S.M., Montazeri, A., Mohagheghi, M.A., Jarrahi, A.M., Harirchi, I., Najafi, M., et al. (2007) Breast Cancer in Iran: An Epidemiological Review. The Breast Journal, 13, 383-391.
http://dx.doi.org/10.1111/j.1524-4741.2007.00446.x
[11] Gotzsche, P.C. and Jorgensen, K.J. (2013) Screening for Breast Cancer with Mammography. John Wiley & Sons, Hoboken.
http://dx.doi.org/10.1002/14651858.cd001877.pub5
[12] Li, C., Uribe, D. and Daling, J. (2005) Clinical Characteristics of Different Histologic Types of Breast Cancer. British Journal of Cancer, 93, 1046-1052.
http://dx.doi.org/10.1038/sj.bjc.6602787
[13] Singletary, S.E. and Connolly, J.L. (2006) Breast Cancer Staging: Working with the Sixth Edition of the AJCC Cancer Staging Manual. CA: A Cancer Journal for Clinicians, 56, 37-47.
[14] Tanase, K., Thies, E.D., Mader, U., Reiners, C. and Verburg, F.A. (2016) The TNM System (Version 7) Is the Most Accurate Staging System for the Prediction of Loss of Life Expectancy in Differentiated Thyroid Cancer. Clinical Endocrinology, 84, 284-291.
http://dx.doi.org/10.1111/cen.12765
[15] Wang, M., Klevebring, D., Lindberg, J., Czene, K., Gronberg, H. and Rantalainen, M. (2016) Determining Breast Cancer Histological Grade from RNA-Sequencing Data. Breast Cancer Research, 18, 1.
http://dx.doi.org/10.1186/s13058-016-0710-8
[16] Islam, M.S., Kabir, E., Jeba, R., Islam, M.N., Khan, H.R. and Begum, S. (2015) Grading of Breast Cancer—A Short Review. Sir Salimullah Medical College Journal, 15, 95-99.
[17] Calonge, N., Petitti, D.B., DeWitt, T.G., Dietrich, A.J., Gregory, K.D., Grossman, D., et al. (2009) Screening for Breast Cancer. Annals of Internal Medicine, 151, 716-726.
http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00008
[18] Li, Y., Tondravi, M., Liu, J., Smith, E., Haudenschild, C.C., Kaczmarek, M., et al. (2001) Cortactin Potentiates Bone Metastasis of Breast Cancer Cells. Cancer Research, 61, 6906-6911.
[19] Dedes, K.J., Lopez-Garcia, M.-A., Geyer, F.C., Lambros, M.B., Savage, K., Vatcheva, R., et al. (2010) Cortactin Gene Amplification and Expression in Breast Cancer: A Chromogenic in Situ Hybridisation and Immunohistochemical Study. Breast Cancer Research and Treatment, 124, 653-666.
http://dx.doi.org/10.1007/s10549-010-0816-0
[20] Sheen-Chen, S.-M., Huang, C.-Y., Liu, Y.-Y., Huang, C.-C. and Tang, R.-P. (2011) Cortactin in Breast Cancer: Analysis with Tissue Microarray. Anticancer Research, 31, 293-297.
[21] MacGrath, S.M. and Koleske, A.J. (2012) Cortactin in Cell Migration and Cancer at a Glance. Journal of Cell Science, 125, 1621-1626.
http://dx.doi.org/10.1242/jcs.093781
[22] Daly, R. (2004) Cortactin Signalling and Dynamic Actin Networks. Biochemical Journal, 382, 13-25.
http://dx.doi.org/10.1042/BJ20040737
[23] Zhao, G., Huang, Z.-M., Kong, Y.-L., Wen, D.-Q., Li, Y., Ren, L., et al. (2013) Cortactin Is a Sensitive Biomarker Relative to the Poor Prognosis of Human Hepatocellular Carcinoma. World Journal of Surgical Oncology, 11, 74.
http://dx.doi.org/10.1186/1477-7819-11-74
[24] Ormandy, C.J., Musgrove, E.A., Hui, R., Daly, R.J. and Sutherland, R.L. (2003) Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer. Breast Cancer Research and Treatment, 78, 323-335.
http://dx.doi.org/10.1023/A:1023033708204
[25] Hirakawa, H., Shibata, K. and Nakayama, T. (2009) Localization of Cortactin Is Associated with Colorectal Cancer Development. International Journal of Oncology, 35, 1271-1276.
http://dx.doi.org/10.3892/ijo_00000444
[26] Tsai, W.-C., Jin, J.-S., Chang, W.-K., Chan, D.-C., Yeh, M.-K., Cherng, S.-C., et al. (2007) Association of Cortactin and Fascin-1 Expression in Gastric Adenocarcinoma: Correlation with Clinicopathological Parameters. Journal of Histochemistry & Cytochemistry, 55, 955-962.
http://dx.doi.org/10.1369/jhc.7A7235.2007
[27] Noh, S.J., Baek, H.A., Park, H.S., Jang, K.Y., Moon, W.S., Kang, M.J., et al. (2013) Expression of SIRT1 and Cortactin Is Associated with Progression of Non-Small Cell Lung Cancer. Pathology-Research and Practice, 209, 365-370.
http://dx.doi.org/10.1016/j.prp.2013.03.011